Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study

Core Insights - ADIA Nutrition Inc. has initiated a clinical study to evaluate the effects of stem cell therapy on children with Autism Spectrum Disorder (ASD) [1][2] - The study aims to enroll around 100 children aged 3-12 diagnosed with ASD, comparing the effects of a proprietary stem cell product combined with glutathione therapy against glutathione therapy alone [3][4] Study Details - The clinical trial, titled "Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study," is a 24-month randomized interventional study [2] - The study is registered on ClinicalTrials.gov with ID NCT07304440 and is currently in the recruitment phase [2] - The primary outcome will be assessed using the Autism Treatment Evaluation Checklist (ATEC) at six months, focusing on safety, tolerability, and overall well-being [3][4] Participation and Costs - Participation is voluntary with a one-time fee of $12,000 covering all treatments and assessments during the study [5][11] - Families can withdraw at any time without penalty, although fees for completed procedures are non-refundable [6] Company Overview - ADIA Nutrition Inc. specializes in stem cell and regenerative products, operating clinics that offer various advanced treatments [8][9] - The company generates revenue through service fees, product sales, and insurance billing for healthcare treatments [9] - ADIA Nutrition is expanding its operations and partnerships to enhance access to regenerative therapies [7][9]